Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Blood Advances|May 16, 2019
Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasmsSanjay S Patel, Caleb Ho, Ryan N Ptashkin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2020
Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1Chi Young Ok, Kevin T Trowell, Kyle G Parker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2019
Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology groupOlga K Weinberg, Robert P Hasserjian, Ezra Baraban, et al.
American Journal of Hematology|April 7, 2020
Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group studyHeesun J Rogers, Xiaoqiong Wang, Yan Xie, et al.
The New England Journal of Medicine|September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaAlfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
American Journal of Clinical Pathology|April 10, 2024
Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group studyGenevieve M Crane, Julia T Geyer, Beenu Thakral, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemiaDonald E Tsai, Selina M Luger, Charalambos Andreadis, et al.
American Journal of Hematology|October 18, 2025
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology GroupTimothy J Kirtek, Weina Chen, Jaryse C Harris, et al.
Haematologica|November 20, 2023
STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophiliaC Cameron Yin, Wayne Tam, Serena M Walker, et al.
Science Translational Medicine|September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemiaDavid L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Pageof 18